Synthetic estrogen is a lab-made compound designed to mimic the effects of the estrogen your body produces naturally. These compounds are chemically altered versions of natural estrogen, engineered to be more potent, longer-lasting, or better absorbed as a pill. The most widely used synthetic estrogen is ethinyl estradiol, the estrogen component in most combined birth control pills. Synthetic estrogens are also used in hormone therapy for menopause and in gender-affirming care.
How Synthetic Estrogen Differs From Natural Estrogen
Your body produces several forms of estrogen, with estradiol being the most active during reproductive years. Natural estradiol, when swallowed as a pill, gets broken down quickly by the liver before much of it reaches the bloodstream. This is called first-pass metabolism, and it’s the core problem synthetic estrogens were designed to solve.
Ethinyl estradiol has a small chemical modification (an ethinyl group) that prevents the liver from breaking it down as rapidly. This makes it dramatically more potent. The doses used in birth control pills are measured in micrograms, typically 20 to 35 millionths of a gram, because so little is needed to produce a strong estrogenic effect. For comparison, hormone therapy for menopause uses milligram-level doses of natural estradiol, which is orders of magnitude more by weight but produces a milder systemic effect.
Common Types of Synthetic and Modified Estrogens
Not every estrogen used in medicine is purely synthetic. The category includes fully synthetic compounds and estrogens derived from animal or plant sources that are then processed in a lab. The most common forms include:
- Ethinyl estradiol: The most potent estrogen available in medicine, used primarily in combined oral contraceptives. It remains the dominant estrogen in birth control despite decades of research into alternatives.
- Conjugated equine estrogens (brand name Premarin): Derived wholly or partially from the urine of pregnant mares. These contain a mix of estrogen compounds, including estrone and equilin, and were the standard hormone therapy for menopause for decades.
- Estradiol valerate: A modified form of natural estradiol, available as an injection or pill. It converts to estradiol in the body and is used in both hormone therapy and some newer oral contraceptives.
There’s also a growing category called “body-identical” hormones, which are lab-manufactured but chemically identical to the estradiol your body makes. These are distinct from synthetic estrogens because they replicate the natural molecule exactly rather than altering it. Current clinical guidance from the International Menopause Society notes that body-identical hormone therapy appears to offer some advantages over conjugated estrogens, though most types of estrogen relieve menopause symptoms effectively when dosed properly.
What Synthetic Estrogen Does in the Body
Synthetic estrogens bind to the same receptors as your natural estrogen, triggering the same biological responses: thickening the uterine lining, regulating ovulation, maintaining bone density, and influencing cholesterol levels. The key difference is how strongly and where in the body they act.
Because oral synthetic estrogens pass through the liver before reaching the rest of the body, they have an outsized effect on liver function compared to estrogen delivered through the skin. The liver responds by ramping up production of several proteins, including clotting factors and proteins that bind to sex hormones. This liver-heavy effect is why oral estrogens carry different risks than patches or gels, which bypass the liver and enter the bloodstream directly.
Blood Clot Risk and Route of Delivery
The most significant safety concern with synthetic oral estrogens is an increased risk of blood clots, particularly deep vein thrombosis and pulmonary embolism. A meta-analysis of 15 observational studies found that oral estrogen therapy was associated with a 63% higher risk of a first blood clot episode compared to transdermal (patch or gel) estrogen in postmenopausal women. The risk of deep vein thrombosis specifically was about twice as high with oral estrogen.
This difference comes down to the liver effect. Oral estrogens stimulate the liver to produce more clotting factors, tipping the balance toward clot formation. Transdermal estrogen largely avoids this because it enters the bloodstream without passing through the liver first. For people with a history of blood clots or obesity, transdermal delivery is generally preferred. However, for healthy women at the typical age of menopause with no particular risk factors, oral estrogen remains a reasonable option if they prefer it.
Women who develop a blood clot while taking oral hormones can reduce their risk of recurrence by switching to transdermal estrogen. In transgender women with a prior history of clots, transdermal estrogen is considered the first choice for feminizing hormone therapy.
Synthetic Estrogen vs. Phytoestrogens
Plant-based estrogens, called phytoestrogens, are sometimes discussed as natural alternatives to synthetic estrogen. These compounds, found in soy, flaxseed, and red clover, do bind to estrogen receptors, but with far less strength. Phytoestrogens have a significantly lower binding affinity for estrogen receptors than estradiol, and they tend to preferentially activate one type of estrogen receptor (beta) over the other (alpha). This gives them a much weaker and more selective effect.
In practical terms, phytoestrogens are not interchangeable with synthetic estrogens for contraception or managing moderate to severe menopause symptoms. Their effects are subtle enough that they function more like very weak estrogen signals, which can be mildly helpful for some symptoms but are not strong enough to suppress ovulation or reliably control hot flashes the way pharmaceutical estrogens do.
Environmental Persistence
One underappreciated aspect of synthetic estrogen is what happens after it leaves the body. Ethinyl estradiol is excreted in urine and enters wastewater treatment plants, which don’t fully remove it. From there, it reaches rivers, lakes, and streams at very low concentrations. Unlike natural estrogens, ethinyl estradiol is more resistant to breakdown in the environment, making it “pseudo-persistent” since it’s continuously introduced through wastewater.
Even at trace levels, this has measurable effects on aquatic life. Researchers have documented feminized male fish and skewed sex ratios in fish populations downstream of wastewater treatment plants, effects consistent with chronic low-level estrogen exposure. In the vast majority of U.S. waterways (roughly 99%), predicted concentrations of ethinyl estradiol fall below the threshold for chronic harm to aquatic organisms. But in about 1% of water segments, particularly those heavily dominated by wastewater effluent, concentrations can exceed that safety threshold by up to fivefold.
The Shift Toward Body-Identical Estrogen
Medical practice has been gradually moving away from synthetic estrogens and toward body-identical estradiol, particularly for menopause hormone therapy. Transdermal estradiol patches, gels, and sprays now represent the preferred approach for many clinicians because they avoid the liver effects that drive clotting risk. The International Menopause Society’s 2024 guidance supports this trend, noting that transdermal estradiol carries no increased risk of venous blood clots based on observational and case-controlled studies.
For contraception, ethinyl estradiol remains dominant, though newer pills using estradiol valerate paired with a progestin are available. These aim to provide effective birth control with a gentler metabolic profile, though they haven’t replaced ethinyl estradiol-based pills as the standard. Despite biological differences between estrogen types, evidence of clinically significant differences in how well they work remains limited. Most types of estrogen will effectively treat vasomotor symptoms like hot flashes and vaginal dryness when used at adequate doses.